Loading
Flotufolastat is a third PSMA PET tracer, with a radiohybrid chemistry designed to be reused for therapy.
Flotufolastat F-18 (Posluma) is a radiohybrid PSMA ligand: a silicon-fluoride acceptor allows 18F labelling for PET while the same scaffold can carry 177Lu for therapy, so imaging and treatment agents share one chemistry. It is used for PSMA PET in men with prostate cancer at initial staging and at biochemical recurrence. The LIGHTHOUSE (initial staging) and SPOTLIGHT (biochemical recurrence) trials supported approval in May 2023. Low urinary excretion aids reading of the pelvis, where bladder activity can obscure local recurrence with other tracers. It is the third PSMA PET tracer in the US after gallium-68 PSMA-11 and Pylarify, and head-to-head comparisons are limited. For a newcomer, it is a PSMA scan agent designed from the start to be reused for therapy.
Ball-and-stick model from PubChem 2D record (no 3D conformer available). PubChem record
Radiohybrid PSMA ligand; silicon-fluoride acceptor allows 18F imaging and 177Lu therapy on the same scaffold. Connects to PSMA.
1.Flotufolastat F-18 slips into a pocket on PSMA.
Diagnostic radiopharmaceutical billed with the PET/CT scan under Part B; same coverage pathway as other PSMA PET agents.
Commercial plans cover PSMA PET for staging and recurrence with prior authorisation of the imaging procedure.
Sources: Medicare.gov: Chemotherapy · Medicare.gov: Prescription drugs (outpatient, Part B) · Medicare.gov: Diagnostic non-laboratory tests (imaging). Not medical or financial advice; verify with your plan.
Sources: NICE search: flotufolastat F-18. Funding decisions are indication-specific and change monthly; verify with NICE and your treating team.
Compare all products across the US, EU, UK, Japan, China and Australia →
| Region | Year | Indication |
|---|---|---|
| US | 2023 | PSMA PET in prostate cancer |
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"Flotufolastat F-18" OR ABSTRACT:"Flotufolastat F-18" OR TITLE:"Posluma" OR ABSTRACT:"Posluma" OR TITLE:"18F-rhPSMA-7.3" OR ABSTRACT:"18F-rhPSMA-7.3") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Flotufolastat F-18, not a curated reading list.
Shares PSMA expression by PET (PSMA-positive), PSMA, PSMA PET, Prostate cancer.
Shares PSMA expression by PET (PSMA-positive), PSMA, PSMA PET, Prostate cancer.
Shares PSMA expression by PET (PSMA-positive), PSMA, PSMA PET, Prostate cancer.
Shares PSMA expression by PET (PSMA-positive), PSMA, PSMA PET, Prostate cancer.
Shares PSMA expression by PET (PSMA-positive), PSMA, PSMA PET, Prostate cancer.
Shares PSMA, PSMA PET, Prostate cancer.
Shares PSMA expression by PET (PSMA-positive), PSMA, PSMA PET, Prostate cancer.
Shares PSMA, PSMA PET, Prostate cancer.